[Federal Register Volume 77, Number 185 (Monday, September 24, 2012)]
[Notices]
[Page 58843]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-23390]



[[Page 58843]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices (ACIP)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
committee:

Times and Dates

    8 a.m.-6 p.m., October 24, 2012.
    8 a.m.-4 p.m., October 25, 2012.
    Place: Centers for Disease Control and Prevention, Tom Harkin 
Global Communications Center, 1600 Clifton Road NE., Building 19, Kent 
``Oz'' Nelson Auditorium, Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The committee is charged with advising the Director, CDC, 
on the appropriate uses of immunizing agents. In addition, under 42 
U.S.C. 1396s, the committee is mandated to establish and periodically 
review and, as appropriate, revise the list of vaccines for 
administration to vaccine-eligible children through the Vaccines for 
Children (VFC) program, along with schedules regarding the appropriate 
periodicity, dosage, and contraindications applicable to the vaccines. 
Further, under provisions of the Affordable Care Act, at section 2713 
of the Public Health Service Act, immunization recommendations of the 
ACIP that have been adopted by the Director of the Centers for Disease 
Control and Prevention must be covered by applicable health plans.
    Matters To Be Discussed: The agenda will include discussions on: 
2013 adult immunization schedule, 2013 child/adolescent immunization 
schedule, Japanese encephalitis, rotavirus, human papillomavirus 
vaccines, hepatitis B vaccine, meningococcal vaccines, influenza, 
measles-mumps-rubella vaccine, pertussis and vaccine supply. 
Recommendation votes are scheduled for pertussis vaccines, 
meningococcal vaccines, measles-mumps-rubella vaccine, hepatitis B 
vaccine, child/adolescent immunization schedule, and the adult 
immunization schedule. VFC votes are scheduled for pertussis vaccines, 
meningococcal vaccines, and influenza vaccine. Time will be available 
for public comment.
    Agenda items are subject to change as priorities dictate.
    Meeting is webcast live via the World Wide Web; for instructions 
and more information on ACIP please visit the ACIP web site: http://www.cdc.gov/vaccines/acip/index.html.
    Contact Person for More Information: Stephanie B. Thomas, National 
Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton 
Road NE., MS-A27, Atlanta, Georgia 30333, telephone 404/639-8836; Email 
ACIP@CDC.GOV.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both the Centers for Disease Control and Prevention and the Agency for 
Toxic Substances and Disease Registry.

    Dated: September 14, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2012-23390 Filed 9-21-12; 8:45 am]
BILLING CODE 4160-18-P